Tag: Tepezza
Amgen to buy Horizon Therapeutics in $26.4B deal
SHERMAN OAKS, Calif. (AP) – Amgen Inc. is spending more than $26 billion to dive deeper into rare disease treatments with a deal for...
TOPICS
PBN's All Access Subscription
PBN subscribers get ahead with unlimited access to PBN news, information, and insights from our editorial team, research and data, webinars and much more.
PBN's Daily Newsletters
Get PBN's top stories and breaking news every day in your email inbox.
Helping you succeed in business since 1986.
© Providence Business News. All Rights Reserved.

